Status:
COMPLETED
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Pain
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is the determination of blood concentration and the effectiveness of esketamine after nasal application.
Eligibility Criteria
Inclusion
- male
- age ≥18 years ≤ 45 years
- healthy
- non-smoking
- BMI 18-27
Exclusion
- abuse of drugs
- known or supposed hypersensitivity and/or contraindication against ketamine or additives
- participation of another clinical study within the last 30 days
- chronic obstructed nose breathing or nasal polyps
- dug allergy
- blood donation within the last two months
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
End Date :
October 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00847418
Start Date
February 1 2009
End Date
October 1 2009
Last Update
December 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center, University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031